The Framework Agreement is for the supply of Patient Dry Wipes for use on patient skin, all products must be suitable for use in the healthcare and healthcare-related environment. The Framework Agreement will have an initial term of 36 months with an option to extend incrementally for up to a total period of 48 months. It is anticipated that in the first 36 months of the Framework Agreement the value of purchases will be in the region of £18, 000,000 GBP Exc VAT. For the full 48 month term (if extended) the anticipated value is £24,000,000 GBP Exc VAT. Further estimated values in respect of each of the Lots is set out below. These values are approximate only and are based on the most recent historical usage information, with a forecasted level of growth. The values provided are for guidance only and are not a guarantee of business.
8 suppliers across 2 lots
This Lot is for Non-maceratable Dry Wipes, that are not disposed of in a macerator after use. This includes 100% synthetic wipes and mixed blend wipes. Additional information: The anticipated value of purchases will be circa £12,000,000 for the first 36 months of the Framework Agreement and £16,000,000 for the full term of the 48 months (if extended).
This Lot is for Patient dry wipes that are disposed of in a macerator after use. Wipes are comprised of cellulosic material. Additional information: The anticipated value of purchases will be circa £6,000,000 for the first 36 months of the Framework Agreement and £8,000,000 for the full term of the 48 months (if extended).
Awarded contracts called off from this framework agreement.
Buyers and suppliers active on the Patient Dry Wipes framework, ranked by contract award volume.
Suppliers ranked by total contract award volume through Patient Dry Wipes.
Buyers ranked by total contract award volume through Patient Dry Wipes.
From first signal to bid submission, Stotles turns procurement chaos into predictable pipeline.
